WaveMan · Form 4
Arnold Frances insider trades
> Search tickers & screens ⌘K
LIVE

Arnold Frances insider trades

Arnold Frances has filed 62 Form 4s with the SEC that we hold, for Alphabet Inc. (GOOGL) (Director), Illumina, INC. (ILMN) (Director) and Generate Biomedicines, Inc. (GENB) (Director). Across all of them we count 0 purchases worth $0 and 40 sales worth $1.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 12 sales ($393.1K). The largest single trade was a sale of 1,230 shares of Alphabet Inc. worth $143.2K, dated 2022-07-29. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-09 and the latest 2026-10-02.

Alphabet Inc. (GOOGL)

Director · 56 filings · 40 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-04S, sale reported on Form 450$142.9K2022-02-08
2022-07-29S, sale reported on Form 41,230$143.2K2022-07-29
2023-05-25S, sale reported on Form 4950$119.0K2023-05-26
2023-05-31S, sale reported on Form 4240$29.7K2023-05-31
2023-06-29S, sale reported on Form 4240$28.8K2023-06-29
2023-07-28S, sale reported on Form 4230$30.1K2023-07-28
2023-08-30S, sale reported on Form 4230$31.2K2023-09-01
2023-09-28S, sale reported on Form 4240$31.4K2023-09-28
2023-10-30S, sale reported on Form 4250$31.1K2023-10-30
2023-11-30S, sale reported on Form 4230$31.4K2023-11-30
2023-12-29S, sale reported on Form 4240$33.7K2023-12-29
2024-01-30S, sale reported on Form 4230$35.4K2024-01-30
2024-02-29S, sale reported on Form 4100$13.8K2024-02-29
2024-03-28S, sale reported on Form 490$13.7K2024-03-29
2024-04-30S, sale reported on Form 480$13.4K2024-04-30
2024-11-04S, sale reported on Form 4441$75.4K2024-11-04
2024-11-29S, sale reported on Form 4111$18.9K2024-12-02
2024-12-31S, sale reported on Form 4111$21.4K2025-01-02
2025-01-30S, sale reported on Form 4110$22.0K2025-01-30
2025-02-28S, sale reported on Form 4121$20.6K2025-02-28
2025-03-28S, sale reported on Form 4111$18.0K2025-03-31
2025-04-30S, sale reported on Form 4111$17.7K2025-05-01
2025-05-30S, sale reported on Form 4111$19.1K2025-06-02
2025-06-30S, sale reported on Form 4121$21.9K2025-06-30
2025-06-30S, sale reported on Form 4101$19.8K2025-07-31
2025-07-30S, sale reported on Form 4101$19.8K2025-08-21
2025-08-28S, sale reported on Form 4102$21.2K2025-08-29
2025-09-30S, sale reported on Form 4103$25.0K2025-09-30
2025-10-30S, sale reported on Form 4112$32.7K2025-11-03
2025-12-01S, sale reported on Form 4102$32.4K2025-12-02
2025-12-31S, sale reported on Form 4102$32.0K2025-12-31
2026-01-29S, sale reported on Form 4102$34.7K2026-01-30
2026-03-02S, sale reported on Form 4112$33.9K2026-03-04
2026-03-30S, sale reported on Form 4102$28.1K2026-03-31
2026-04-30S, sale reported on Form 4102$37.8K2026-05-01
2026-05-29S, sale reported on Form 4102$38.9K2026-06-01
2026-06-30S, sale reported on Form 4112$39.3K2026-06-30
2026-07-30S, sale reported on Form 482$27.3K2026-07-30
2026-08-28S, sale reported on Form 482$27.7K2026-08-31
2026-09-30S, sale reported on Form 483$28.3K2026-10-02

Illumina, INC. (ILMN)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Generate Biomedicines, Inc. (GENB)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1665419) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms